Information only — not investment advice; no trading here. Every number shows when it was observed and where it came from; stale sources are labelled as stale.

JNJ JOHNSON & JOHNSON

equity · exchange NYSE · CIK 0000200406 · trades in USD

AI brief AI-written, not reviewed by a person

Latest available figures show JNJ's cash and equivalents around 16.91B at 2026-09-27 (down from 20.42B at 2026-06-28), stockholders’ equity near 81.53B at 2026-09-27 (down from 84.97B at 2026-06-28), and long-term debt approximately 35.80B at 2026-09-27 (vs 37.34B at 2026-06-28). Yearly diluted EPS grew to 11.03 USD for the twelve months ending 2025-12-28 from 5.79 USD for the twelve months ending 2024-12-29, while revenue for the year rose to 94.19B in 2025 from 88.82B in 2024. These figures are drawn from SEC filings and correspond to consecutive quarterly and annual periods available in the cited documents.

Written by OpenVibe.AI from the SEC numbers and filings on this page, not reviewed by a person. Informational only; not investment advice. Written from figures and filings up to (gpt-5-nano-2025-08-07).

What the sources did not support
  • No figures beyond the provided SEC filing items; some metrics (e.g., quarterly operating cash flow) are included but not consistently tied to the latest staleness window.
  • Some items (e.g., current liabilities, detailed segment data) are not present in the provided sources.

Observations

Latest observation per metric. Values are exactly as the source stated them.
MetricValueObservedSourceRetrievedFreshness
Revenue (quarter) (3 months to 2026-09-27) 25,399,000,000 USD sec-companyfacts current
Revenue (year) (12 months to 2025-12-28) 94,193,000,000 USD sec-companyfacts current
Net income (quarter) (3 months to 2026-09-27) 210,000,000 USD sec-companyfacts current
Net income (year) (12 months to 2025-12-28) 26,804,000,000 USD sec-companyfacts current
Operating income (quarter) (3 months to 2015-03-29) 5,827,000,000 USD sec-companyfacts current
Operating income (year) (12 months to 2014-12-28) 21,590,000,000 USD sec-companyfacts current
Diluted EPS (quarter) (3 months to 2026-09-27) 0.09 USD/shares sec-companyfacts current
Diluted EPS (year) (12 months to 2025-12-28) 11.03 USD/shares sec-companyfacts current
Operating cash flow (quarter) (3 months to 2026-03-29) 2,514,000,000 USD sec-companyfacts current
Operating cash flow (year) (12 months to 2025-12-28) 24,530,000,000 USD sec-companyfacts current
Total assets (at 2026-09-27) 197,425,000,000 USD sec-companyfacts current
Total liabilities (at 2026-09-27) 115,896,000,000 USD sec-companyfacts current
Stockholders' equity (at 2026-09-27) 81,529,000,000 USD sec-companyfacts current
Cash and equivalents (at 2026-09-27) 16,910,000,000 USD sec-companyfacts current
Long-term debt (at 2026-09-27) 35,799,000,000 USD sec-companyfacts current
Shares outstanding (at 2026-10-15) 2,407,310,266 shares sec-companyfacts current

Context

No reviewed context has been published for JNJ. The observations and documents below are shown as their sources stated them.

Documents

Feeds of JNJ documents: RSS · Atom · JSON Feed

Source freshness

Sources behind this page. A source is stale when its last successful fetch is older than its window.
SourceFreshnessLast successful fetchStale afterSources reports
SEC EDGAR: company financial facts (XBRL) sec-companyfacts current 10080 min ok
SEC EDGAR: latest XBRL filings sec-xbrl-filings current 45 min healthy

Watch this instrument

Sign in to add JNJ to a private watchlist or to get an alert when a new document or observation arrives.

Machine-readable: JNJ.json (the same data with every timestamp and source).

Information only — not investment advice; no trading here. OpenVibe.Trade holds no money or assets, takes no orders and gives no personal recommendations.